학술논문

Estimation of Ischemia Modified Albumin (IMA) Levels in Patients with Acute Coronary Syndrome
Document Type
Academic Journal
Source
Indian Journal of Clinical Biochemistry. July 2014, Vol. 29 Issue 3, p367, 5 p.
Subject
Heart attack -- Care and treatment
Unstable angina -- Care and treatment
Ischemia -- Care and treatment
Albumin
Cardiac patients -- Care and treatment
Chemistry
Care and treatment
Language
English
ISSN
0970-1915
Abstract
Myocardial ischemia produces free radicals that catalyze a series of oxidative reactions that damage healthy tissues. The N-terminal sequence of albumin is one of the proteins modified by these highly reactive oxygen species and forms the ischemia modified albumin (IMA). This study involves investigations undertaken in different study groups to assess the levels of IMA. Mean serum IMA levels (U/mL) in patients with ST-segment elevated myocardial infarction (92.1 ± 10.6), non-ST-segment elevated myocardial infarction (87.3 ± 5.95) and unstable angina (UA) (88.9 ± 6.16) were significantly higher than non-cardiac chest pain (77.9 ± 6.69) and also healthy subjects (54.7 ± 17.2) (p < 0.001). IMA is a highly sensitive marker and has a high predictive value, which might prove the usefulness of this biomarker for early detection of myocardial ischemia. These data indicate a possible role of the IMA test in the early triage of patients with chest pain.
Author(s): Prema Gurumurthy [sup.1], Sai Krishna Borra [sup.1], Rama Krishna Reddy Yeruva [sup.1], Dolice Victor [sup.1], Sai Babu [sup.1], K. M. Cherian [sup.2] Author Affiliations: (1) grid.464800.e, Department of Biochemistry, [...]